<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03182387</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2015/38</org_study_id>
    <nct_id>NCT03182387</nct_id>
  </id_info>
  <brief_title>Key to Improve DiagNosis in Aspiration Pneumonia</brief_title>
  <acronym>KIDNAP</acronym>
  <official_title>Evaluation du Dosage de l'Amylase Dans le Liquide Broncho Alveolaire Dans le Diagnostic précoce de la Pneumopathie d'Inhalation Infectieuse du Sujet Comateux intubé-ventilé.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the diagnostic performance of amylase assay performed from bronchial alveolar
      fluid to differentiate aseptic chemical inhalation pneumonitis from an infectious inhalation
      pneumonitis in comatose patients with intubated ventilation for less than 24 hours.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Validation of the potential diagnostic performance of amylase assay compared to gold standard
      in diagnosis of infectious inhalation pneumonia of the comatose patient enabling the
      realization of a multicentric study using this innovative method in a diagnostic strategy
      with the objective of reducing the consumption of antibiotics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 21, 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificityof amylase test.</measure>
    <time_frame>5 days after inclusion day</time_frame>
    <description>Amylase culture in bronchoalveolar fluid is compared to gold standard culture</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Infectious Pneumonia</condition>
  <condition>Coma</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bronchoalveolar fluid.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient admitted to ICU with mechanical ventilation need.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient intubated ≤ 24 hours for unconsciousness (stroke, meningitis, drug
             intoxication, metabolic disorders, epilepticus, cardiac arrest).

          -  Inhalation table with hypoxemic acute respiratory insufficiency post-consciousness +
             chest x-ray revealing one or more compatible infiltrates + t °&gt; 38 ° C).

          -  Age ≥18 years

          -  Patient affiliated to the social security system.

          -  No opposition obtained

        Exclusion Criteria:

          -  Immunocompromised patient.

          -  Cardiorespiratory arrest requiring therapeutic hypothermia.

          -  Pneumopathy nosocomiale (pneumopathy beginning&gt; 48h after hospital admission).

          -  Infectious Pneumonia in the previous 30 days.

          -  Previous hospitalization in the previous 30 days.

          -  Patient under antibiotic at baseline.

          -  Bacteremia.

          -  Mechanical ventilation begun before unconsciousness.

          -  Report Pa02 / FI02 &lt;80.

          -  Patient under curatorship and / or guardianship.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wittkop Linda, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>USMR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laterrade Thomas, MD</last_name>
    <phone>05 56 79 98 29</phone>
    <phone_ext>+33</phone_ext>
    <email>thomas.laterrade@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Boyer Alexandre, Pr</last_name>
    <email>alexandre.boyer@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laterrade Thomas, MD</last_name>
      <phone>05 56 79 98 29</phone>
      <email>thomas.laterrade@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Boyer Alexandre, Pr</last_name>
      <email>alexandre.boyer@chu-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>November 10, 2017</last_update_submitted>
  <last_update_submitted_qc>November 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchoalveolar lavage</keyword>
  <keyword>amylase assay</keyword>
  <keyword>aspiration pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

